首页> 美国卫生研究院文献>Acta Crystallographica Section F: Structural Biology and Crystallization Communications >Purification crystallization and preliminary X-ray diffraction analysis of disease-related mutants of p97
【2h】

Purification crystallization and preliminary X-ray diffraction analysis of disease-related mutants of p97

机译:与疾病相关的p97突变体的纯化结晶和初步X射线衍射分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The human type II AAA+ protein p97 participates in various cellular activities, presumably through its involvement in the ubiquitin–proteasome degradation pathway. Mutations in p97 have been implicated in patients with inclusion-body myopathy associated with Paget’s disease of the bone and frontotemporal dementia (IBMPFD). In this work, three mutant p97 N-D1 fragments, R86A, R95G and R155H, were crystallized in the presence of ATPγS with PEG 3350 as a main precipitant, yielding two different crystal forms. The R155H mutant crystal belonged to space group R3, with unit-cell parameters in the hexagonal setting of a = b = 134.2, c = 182.9 Å, and was merohedrally twinned, with an estimated twin fraction of 0.34. The crystals of the R86A and R95G mutants belonged to space group P1, with similar unit-cell parameters of a = 90.89, b = 102.6, c = 107.2 Å, α = 97.5, β = 90.6, γ = 91.5° and a = 92.76, b = 103.7, c = 107.7 Å, α = 97.7, β = 91.9, γ = 89.7°, respectively.
机译:人类II型AAA +蛋白p97可能通过参与泛素-蛋白酶体降解途径而参与各种细胞活动。 p97基因突变与患有佩吉特氏骨病和额颞叶性痴呆(IBMPFD)的包涵​​体肌病有关。在这项工作中,三个突变的p97 N-D1片段R86A,R95G和R155H在ATPγS的存在下以PEG 3350为主要沉淀剂进行了结晶,产生了两种不同的晶体形式。 R155H突变体晶体属于空间群R3,其晶胞参数在a = b = 134.2,c = 182.9的六边形环境中,并进行了多面体孪晶,估计孪生分数为0.34。 R86A和R95G突变体的晶体属于空间群P1,具有相似的晶胞参数,a = 90.89,b = 102.6,c = 107.2Å,α= 97.5,β= 90.6,γ= 91.5°,a = 92.76 ,b = 103.7,c = 107.7,α= 97.7,β= 91.9,γ= 89.7°。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号